Portable Vibronic Near-Infrared Tumor Disruption Platform: A Preclinical Translational Proposal for Feedback-Controlled Molecular Activation Therapy

This preprint presents a conceptual translational proposal for a portable near-infrared (NIR) vibronic tumor disruption platform inspired by recent aminocyanine molecular activation studies. The proposed system integrates targeted cyanine-based molecular agents, adaptive optical excitation, fluorescence-assisted feedback control, and low-thermal operation to explore non-conventional photonic approaches for selective tumor cell disruption. The manuscript outlines the scientific background, proposed engineering architecture, feedback-control framework, potential applications, and key limitations of the approach while emphasizing that the platform remains preclinical and experimentally unvalidated for human therapeutic use.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-12
DOI
https://doi.org/10.5281/zenodo.20130330
Primary Topic
Nanoplatforms for cancer theranostics
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Portable Vibronic Near-Infrared Tumor Disruption Platform: A Preclinical Translational Proposal for Feedback-Controlled Molecular Activation Therapy

Francis Procaccia
Zenodo (CERN European Organization for Nuclear Research)
Nanoplatforms for cancer theranostics
preprint

Portable Vibronic Near-Infrared Tumor Disruption Platform: A Preclinical Translational Proposal for Feedback-Controlled Molecular Activation Therapy

Francis Procaccia
preprint en

Abstract

This preprint presents a conceptual translational proposal for a portable near-infrared (NIR) vibronic tumor disruption platform inspired by recent aminocyanine molecular activation studies. The proposed system integrates targeted cyanine-based molecular agents, adaptive optical excitation, fluorescence-assisted feedback control, and low-thermal operation to explore non-conventional photonic approaches for selective tumor cell disruption. The manuscript outlines the scientific background, proposed engineering architecture, feedback-control framework, potential applications, and key limitations of the approach while emphasizing that the platform remains preclinical and experimentally unvalidated for human therapeutic use.

Zenodo (CERN European Organization for Nuclear Research)
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.